Results 111 to 120 of about 2,570 (187)
Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations
Heterozygous mutations in GBA, the gene encoding the lysosomal enzyme glucosylceramidase beta/β-glucocerebrosidase, comprise the most common genetic risk factor for Parkinson disease (PD), but the mechanisms underlying this association remain unclear ...
Donghoon Kim (832917) +13 more
core +1 more source
Rare neurological diseases (RND) represent a growing but underrecognized global health burden, particularly in aging populations in whom clinical manifestations appear later in life, resulting in substantial morbidity, reduced quality of life, and ...
Nathan D. Phan +3 more
doaj +1 more source
Skin lipid abnormalities in Gaucher's disease
In the epidermis of terrestrial vertebrates stratum corneum lipids are known to play an important role as regulators of skin permeability; particularly ceramides, some of which with very long chain, hydroxy fatty acids, are important components of this ...
G. Montorfano +5 more
core
Structural analysis of saposin C and B. Complete localization of disulfide bridges.
Saposins A, B, C, and D are a group of homologous glycoproteins derived from a single precursor, prosaposin, and apparently involved in the stimulation of the enzymatic degradation of sphingolipids in lysosomes. All saposins have six cysteine residues at
Ciaffoni F +9 more
core
Early⁃onset Parkinson's disease caused by LRRK2 R1067Q and GBA R202Q variation: one case report
LIU Chen +3 more
doaj +1 more source
Immune system role on gaucher disease
Trabalho Final de Mestrado Integrado, Ciências Farmacêuticas, Universidade de Lisboa, Faculdade de Farmácia, 2014The Gaucher Disease (GD) is the most prevalent lysosomal illness in humans and it is caused by the deficiency in the enzyme ...
Duarte, André Alexandre Rodrigues Besouro
core +1 more source
Phenotypic Spectrum of Type 2-3 Gaucher Disease: A Case Study in the Balkan Genotype. [PDF]
Cullufi P +8 more
europepmc +1 more source
GBA3 as a regulator of sphingolipid metabolism in the progression of hepatocellular carcinoma. [PDF]
Wang X, Li L, Sun T, Qiu Z.
europepmc +1 more source
Diagnosis and follow-up of the first case of Gaucher disease under enzyme replacement therapy in Senegal. [PDF]
Keita M +7 more
europepmc +1 more source

